[CERO] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[CERO] CERo Therapeutics Holdings, Inc.
Announcement Date
30-Mar-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -83.27%
YoY- -27.51%
Quarter Report
CERO's Result
CERO's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 CAGR
Revenue 0 0 0 -
PBT -2,300 -482 -378 146.36%
Tax -0 -274 0 -
NP -2,300 -482 -378 146.36%
Tax Rate - - - -
Total Cost 2,300 482 378 146.36%
Ratio Analysis
31/03/24 31/03/23 31/03/22 CAGR
NP Margin 0.00 0.00 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 CAGR
EPS -0.16 -0.07 -0.02 182.44%
EPS Diluted -0.16 -0.07 -0.02 182.44%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.